This study is in progress, not accepting new patients
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
Renal Cell Carcinoma Progression-free survival Abexinostat Pazopanib RECIST Cancer therapy Carcinoma Carcinoma, Renal Cell Pazopanib plus abexinostat
Lead Scientists at UCSF
- Pamela Munster, M.D.
Professor, Medicine. Authored (or co-authored) 121 research publications
- Rahul Aggarwal, M.D.
I am a Medical Oncologist within the Division of Hematology/Oncology at the University of California San Francisco. My clinical practice focuses on patients with advanced solid tumor malignancies with a particular emphasis on genitourinary malignancies including prostate, kidney, bladder, and testicular cancer. I serve as the Co-Leader for the GU Medical Oncology program at UCSF.
- in progress, not accepting new patients
- Start Date
- Completion Date
- Xynomic Pharmaceuticals, Inc.
- Phase 3
- Study Type
- Last Updated